| PSIJX | VISGX | PSIJX / VISGX | |
| Total Expense Ratio | 1.14 | 0.19 | 600% |
| Annual Report Gross Expense Ratio | 1.16 | 0.19 | 611% |
| Fund Existence | 25 years | 28 years | - |
| Gain YTD | 23.828 | 17.346 | 137% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.59B | 47B | 6% |
| Annual Yield % from dividends | 0.00 | 0.31 | - |
| Returns for 1 year | 16.45 | 26.83 | 61% |
| Returns for 3 years | 20.11 | 51.09 | 39% |
| Returns for 5 years | -20.79 | 27.48 | -76% |
| Returns for 10 years | 12.96 | 180.44 | 7% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CRCD | 6.59 | 0.58 | +9.65% |
| T-REX 2X Inverse CRCL Daily Target ETF | |||
| OPER | 100.21 | 0.01 | +0.01% |
| ClearShares Ultra-Short Maturity ETF | |||
| SNPD | 29.96 | N/A | N/A |
| Xtrackers S&P Div Arstcrts Scrn ETF | |||
| BME | 42.95 | -0.06 | -0.14% |
| Blackrock Health Sciences Trust | |||
| DFAE | 38.14 | -1.27 | -3.22% |
| Dimensional Emerging Core Equity Mkt ETF | |||